How many older adults receive drugs of questionable clinical benefit near the end of life? A cohort study.

CONCLUSION: A substantial share of older persons with life-limiting diseases receive drugs of questionable clinical benefit during their last months of life. Adequate training, guidance and resources are needed to rationalize and deprescribe drug treatments for older adults near the end of life. PMID: 31172885 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31172885?dopt=Abstract

Source: Palliative Medicine - June 6, 2019 Category: Palliative Care Authors: Morin L, Wastesson JW, Laroche ML, Fastbom J, Johnell K Tags: Palliat Med Source Type: research